Biocon Limited (BIOCON.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 493.49B |
| Enterprise Value | 615.89B |
| P/E Ratio | 124.06 |
| PEG Ratio | -4.88 |
| Price/Sales Ratio | 3.47 |
| Price/Book Ratio | 1.74 |
| Enterprise/Revenue | 4.23 |
| Enterprise/EBITDA | 22.14 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.03 |
| Operating Margin | 0.08 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 169.27B |
| Revenue/Share | 106.86 |
| Gross Profit | 58.85B |
| EBITDA | 33.95B |
| Net Income | 3.86B |
| Diluted EPS | 2.82 |
Balance Sheet
| Total Cash | 26.87B |
| Total Cash/Share | 16.49 |
| Total Debt | 156.98B |
| Total Debt/Equity | 0.45 |
| Current Ratio | 1.22 |
| Book Value Per Share | 227.99 |
Price History
| 52-Week Change | -8.61 |
| 52-Week High | 447.15 |
| 52-Week Low | 318.4 |
| Moving Average 50 Days | 365.13 |
| Moving Average 200 Days | 390.49 |
Statistics
| Average Volume | 3.09M |
| Shares Outstanding | 1.63B |
| % Held by Institutions | 0.07 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 0.13 |
| Payout Ratio | 0.15 |
| Last Split Factor | 2:1 |
| Last Split Date | June 12, 2019 |
AD
